Oral Immunotherapy Transforms Lives of Family with Severe Food Allergies
Sheila Loxton, a mother from Ireland, has described how oral immunotherapy has been a transformative experience for her family, particularly for her children, Josh and Erin, who both suffer from severe food allergies. During an interview on RTÉ's Today with Claire Brock, she recounted the harrowing moment when her son Josh, then just two years old, experienced a severe allergic reaction. Despite having a varied diet, he suddenly began to show signs of anaphylaxis after consuming a home-cooked meal. Loxton recalled how quickly Josh's condition deteriorated, with swelling and difficulty breathing, prompting her to call emergency services. At that time, they had no prior knowledge of his food allergies.
Loxton emphasized the need for better awareness and education regarding food allergies in Ireland, particularly the connection between chronic eczema and the potential for developing food allergies later in life. This insight, she believes, could have helped them identify Josh's allergies sooner. The family began to explore treatment options after a similar incident with Erin, leading them to research oral immunotherapy (OIT), a treatment that has been available internationally for about 20 years.
Oral immunotherapy involves gradually introducing small amounts of allergens under medical supervision to help build tolerance. Loxton explained that while it is not a cure, it is a significant step towards desensitizing the immune system. The family now travels to France every six months to access this treatment, which they describe as life-changing. Loxton noted that the treatment has allowed her children to enjoy foods that were previously off-limits, reducing the fear of severe allergic reactions from accidental exposure.
Josh has outgrown some of his allergies, such as those to chickpeas and lentils, but continues to have a peanut allergy, along with new allergies to other nuts. Erin has also faced similar challenges with her allergies. Loxton highlighted the importance of early diagnosis and access to care, especially during the COVID-19 pandemic when their access to medical support was limited.
The mental burden of managing severe food allergies is significant for parents, as Loxton described the constant vigilance required to ensure their children's safety. She pointed out the need for better training for caregivers and educators to support children with allergies. Loxton's advocacy for improved awareness and treatment access reflects the urgent need for comprehensive care for children suffering from food allergies in Ireland.




